These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19762474)

  • 21. Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progression.
    Zhou H; Binmadi NO; Yang YH; Proia P; Basile JR
    Angiogenesis; 2012 Sep; 15(3):391-407. PubMed ID: 22476930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal growth factor receptor inhibition reduces angiogenesis via hypoxia-inducible factor-1α and Notch1 in head neck squamous cell carcinoma.
    Wang WM; Zhao ZL; Ma SR; Yu GT; Liu B; Zhang L; Zhang WF; Kulkarni AB; Sun ZJ; Zhao YF
    PLoS One; 2015; 10(2):e0119723. PubMed ID: 25723392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GATA3 interacts with and stabilizes HIF-1α to enhance cancer cell invasiveness.
    Lin MC; Lin JJ; Hsu CL; Juan HF; Lou PJ; Huang MC
    Oncogene; 2017 Jul; 36(30):4243-4252. PubMed ID: 28263977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AGR2 expression is regulated by HIF-1 and contributes to growth and angiogenesis of glioblastoma.
    Hong XY; Wang J; Li Z
    Cell Biochem Biophys; 2013; 67(3):1487-95. PubMed ID: 23712868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Semaphorin 4D and hypoxia-inducible factor-1α overexpression is related to prognosis in colorectal carcinoma.
    Wang JS; Jing CQ; Shan KS; Chen YZ; Guo XB; Cao ZX; Mu LJ; Peng LP; Zhou ML; Li LP
    World J Gastroenterol; 2015 Feb; 21(7):2191-8. PubMed ID: 25717256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia-induced ROS promotes mitochondrial fission and cisplatin chemosensitivity via HIF-1α/Mff regulation in head and neck squamous cell carcinoma.
    Wu K; Mao YY; Chen Q; Zhang B; Zhang S; Wu HJ; Li Y
    Cell Oncol (Dordr); 2021 Oct; 44(5):1167-1181. PubMed ID: 34460078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis.
    Chang CC; Lin MT; Lin BR; Jeng YM; Chen ST; Chu CY; Chen RJ; Chang KJ; Yang PC; Kuo ML
    J Natl Cancer Inst; 2006 Jul; 98(14):984-95. PubMed ID: 16849681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The critical role of mast cell-derived hypoxia-inducible factor-1α in human and mice melanoma growth.
    Jeong HJ; Oh HA; Nam SY; Han NR; Kim YS; Kim JH; Lee SJ; Kim MH; Moon PD; Kim HM; Oh HA
    Int J Cancer; 2013 Jun; 132(11):2492-501. PubMed ID: 23161568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
    Cohen NA; Lai SY; Ziober AF; Ziober BL
    Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia-inducible factor 1alpha modulates adhesion, migration, and FAK phosphorylation in vascular smooth muscle cells.
    Corley KM; Taylor CJ; Lilly B
    J Cell Biochem; 2005 Dec; 96(5):971-85. PubMed ID: 16149050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha.
    Oh SH; Woo JK; Jin Q; Kang HJ; Jeong JW; Kim KW; Hong WK; Lee HY
    Int J Cancer; 2008 Jan; 122(1):5-14. PubMed ID: 17764071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Correlation and clinical significance of expressions of HIF-1α and Sema4D in colorectal carcinoma tissues].
    Mu L; Wang J; Guo X; Zheng S; Shan K; Jing C; Li L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):388-92. PubMed ID: 24760652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of SENP1 in endothelial cells contributes to hypoxia-driven VEGF expression and angiogenesis.
    Xu Y; Zuo Y; Zhang H; Kang X; Yue F; Yi Z; Liu M; Yeh ET; Chen G; Cheng J
    J Biol Chem; 2010 Nov; 285(47):36682-8. PubMed ID: 20841360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyruvate promotes tumor angiogenesis through HIF-1-dependent PAI-1 expression.
    Jung SY; Song HS; Park SY; Chung SH; Kim YJ
    Int J Oncol; 2011 Feb; 38(2):571-6. PubMed ID: 21132271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen-dependent proteolytic cleavage of semaphorin 4D and plexin-B1 enhances semaphorin 4D-induced apoptosis during postnatal vaginal remodeling in pubescent mice.
    Ito T; Bai T; Tanaka T; Yoshida K; Ueyama T; Miyajima M; Negishi T; Kawasaki T; Takamatsu H; Kikutani H; Kumanogoh A; Yukawa K
    PLoS One; 2014; 9(5):e97909. PubMed ID: 24841081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
    Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
    Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pseudolaric acid B inhibits angiogenesis and reduces hypoxia-inducible factor 1alpha by promoting proteasome-mediated degradation.
    Li MH; Miao ZH; Tan WF; Yue JM; Zhang C; Lin LP; Zhang XW; Ding J
    Clin Cancer Res; 2004 Dec; 10(24):8266-74. PubMed ID: 15623602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylalpinumisoflavone inhibits hypoxia-inducible factor-1 (HIF-1) activation by simultaneously targeting multiple pathways.
    Liu Y; Veena CK; Morgan JB; Mohammed KA; Jekabsons MB; Nagle DG; Zhou YD
    J Biol Chem; 2009 Feb; 284(9):5859-68. PubMed ID: 19091749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VEGF and SEMA4D have synergistic effects on the promotion of angiogenesis in epithelial ovarian cancer.
    Chen Y; Zhang L; Liu WX; Wang K
    Cell Mol Biol Lett; 2018; 23():2. PubMed ID: 29308068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition.
    Rapisarda A; Hollingshead M; Uranchimeg B; Bonomi CA; Borgel SD; Carter JP; Gehrs B; Raffeld M; Kinders RJ; Parchment R; Anver MR; Shoemaker RH; Melillo G
    Mol Cancer Ther; 2009 Jul; 8(7):1867-77. PubMed ID: 19584228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.